Resources:
Find resources by:
Sort by:
Resources from the last:
Box size:
Filer text box:
Topic familiarity:
Grid Layout:
Collections that use this topic:
Collection topics:
Adrenal Bone Cardiovascular Diabetes Endocrine-Disrupting Chemicals Endocrine-Related Cancer Metabolism Neuroendocrinology Obesity Reproduction Steroid and Steroidogenesis Thyroid

Resource Hub Patient safety

Adrenal & Cardiovascular Bone & Calcium Diabetes Endocrine Cancer including late effects Endocrine disruptors Metabolism Neuroendocrinology Obesity Paediatric Pituitary Reproductive Thyroid Parathyroid Hyperparathyroidism Hypercalcaemia Parathyroid Hormone-PTH Diabetes Insipidus Health Equity Virtual Care Patient-Initiated Follow up Job planning Clinical Pathway Referral guides Trainee resources Patient safety Patient Information Sheets Student Early Career Nurse Secondary care
Addison’s Disease Self-Help Group Update - Ambulance care moving away from 'Red flagging'
2024-10-0707Oct2024
Visit our diabetes insipidus resource page
2022-03-1515Mar2022
Congratulations to our latest Endocrine Nurse Grant awardee
2021-10-2727Oct2021
NHS Steroid Emergency Card shortlisted for patient safety award
2021-09-0101Sep2021
New guidance on adrenal insufficiency from exogenous steroids
2021-03-0101Mar2021
Guidance to support implementation of NHS Steroid Emergency Card coming soon
2020-12-2323Dec2020
Download the new GIRFT report for diabetes
2020-11-1717Nov2020
Improve patient safety support the name change of diabetes insipidus
2020-10-0505Oct2020
NHS Steroid Emergency Card for adrenal insufficiency patients is available to order
2020-08-1313Aug2020
NHS Steroid Emergency Card for adrenal insufficiency patients is available to order
2020-08-1313Aug2020
ECE2017 hits the headlines!
2017-05-2222May2017
Consultant Endocrinologist - University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
2014-04-2929Apr2014
Patient safety - Shifting the paradigm
Date not available
How do I....implement patient safety alerts for adrenal insufficiency across my institution
Date not available
Resource not read: Query You and Your Hormones
My journey to becoming a ‘Nightingale Nurse’ – and how the Society played a part
2018-09-1919Sep2018
Endocrinologist 129 Web
2023-11-0101Nov2023
Use of the arginine-stimulated copeptin test in paediatric polyuria-polydipsia syndrome: experience with eleven patients
Date not available
Healthcare professionals’ survey on the inpatient safety of Diabetes Insipidus
Date not available
Adult inpatients on desmopressin: a patient safety initiative using e-prescribing
2015-01-0505Jan2015
The need to update patient safety information on carbimazole
2019-06-1111Jun2019
Cranial Diabetes Insipidus – A survey of patient safety concerns in secondary care
2018-02-1111Feb2018
The safety of steroid replacement and patient's knowledge
2015-01-0505Jan2015
Preliminary analysis of the PRIMAVERA Study: reduxine safety monitoring in patients with alimentary obesity
2015-01-0505Jan2015
Safety profile of Lenvatinib treatment in a mildly symptomatic Covid19 patient
Date not available
Long-Term Safety and Effectiveness of Daily and Weekly GH Treatment in Pediatric Patients
Date not available
Obese subjects have lower satiety
2005-01-0303Jan2005
Introducing technology to improve patient safety in adrenal insufficiency: a proof-of-concept delivery of a new smartphone app in steroid-dependent patients
Date not available
Safety of prescribing for inpatients with cranial diabetes insipidus (CDI): a Southwest Peninsula Audit
2018-02-1111Feb2018
How do I . . . . implement patient safety alerts for adrenal insufficiency across my institution
Date not available
How do I . . . . implement patient safety alerts for adrenal insufficiency across my institution
Date not available
Analysis of safety and efficacy of liraglutide compared with dulaglutide in patients with type 2 diabetes mellitus
2018-08-0505Aug2018
Safely operated two patients in pregnancy with primary hyperparathyroidism
Date not available
Long term safety of Atorvastatin and Fenofibrate therapy in patients with combined hyperlipidemia
2006-04-1212Apr2006
The latest safety and efficacy data of patients treated with Pegvisomant
2006-04-1212Apr2006
Impaired Brain Satiety Responses to a Meal in Children with Obesity
Date not available
Long-Term Safety and Effectiveness of Daily and Weekly Growth Hormone Treatment in Pediatric GHD Patients (4-Years’ Results)
Date not available
Safety alerts for patients at high risk of acute adrenal insufficiency
Date not available
Novel unimolecular peptides targeting GLP-1 and APJ receptors exert potent satiety inducing effects in mice
Date not available
DI patients vote for a name change to pituitary insipidus to improve safety – a survey
2019-06-1111Jun2019
ACROSTUDY – safety and efficacy in a cohort of 110 Naïve patients with acromegaly treated with pegvisomant
2019-01-0505Jan2019
Efficacy and safety of postbiotic supplementation for type 2 diabetes patients: Randomized clinical Ttrial (DELI Diab study)
2024-06-0505Jun2024
Desmopressin prescription safety in adult inpatients: Experience from a quality improvement project
Date not available
Improving patient safety: evaluating the introduction of the Annual Steroid Review and Emergency Alert Systems
2015-04-1111Apr2015
Long-Term Safety and Effectiveness of Growth Hormone Treatment in Pediatric Patients with Growth Hormone Deficiency: Interim Results of LG Growth Study
Date not available
<em>PROKR2</em> Mutations in Patients with Growth Hormone Deficiency and Multiple Pituitary Hormone Deficiency
Date not available
Role of Brainstem Melanocortin System in CCK-mediated Satiety
2003-01-1111Jan2003
Efficacy, safety and pitfalls of glucocorticoid therapy for patients with autoimmune hypophysitis
Date not available
Long-term efficacy and safety of pasireotide in patients with Cushing&#146;s disease: a monocentric experience
2022-07-0505Jul2022
Efficacy and safety of Cinacalcet therapy for patients with primary hyperparathyroidism: A retrospective observational study
2023-02-0505Feb2023
Safety profile of asfotase alfa treatment of patients with hypophosphatasia: a pooled analysis
Date not available
Safety And Efficacy Of Converting Patients With Acromegaly From Long-Acting Octreotide To Pegvisomant
2003-01-1111Jan2003
PRIMAVERA study: sibutramine therapy safety monitoring in patients with obesity
2019-01-0505Jan2019
Investigating the role of FTO in obesity: dysregulation of satiety signalling
2011-01-0404Jan2011
Efficacy and safety of evoglipitin monotherapy in patients with type 2 diabetes
2017-03-0505Mar2017
Efficacy and safety of dopamine agonists in psychiatric patients treated with antipsychotics and presenting a macroprolactinoma
2019-01-0505Jan2019
Safety of primary care-led surveillance for low-risk thyroid cancer patients
2024-06-0505Jun2024
Efficacy and safety of pamidronate in the treatment of parathyroid hormone-dependent hypercalcemia in hospitalized patients
Date not available
Efficacy and safety of liraglutide in morbid obese patients in first year of commercialization in Spain
2013-01-0404Jan2013
Satiety, hunger and gastrointestinal hormones after a test meal in patients after gastric bypass surgery: an association with amino acids
2017-03-0505Mar2017
9.12. Impaired brain satiety responses after weight loss in children with obesity
2023-08-0909Aug2023
Safety of growth hormone replacement therapy (GHRT) in adult patients with GH deficiency: data from kims
2017-03-0505Mar2017
Comparative study on the efficacy and safety of various regimens of glucocorticoid therapy in patients with COVID-19 and Diabetes Mellitus
2023-02-0505Feb2023
Role of AMP-activated kinase in the control of insulin secretion and satiety
2006-01-1010Jan2006
Design and Objectives of the Acorn Study: A Non-Interventional Study Evaluating Long-term Safety in Achondroplasia Patients Treated with Vosoritide
Date not available
Clinical and safety profile of empagliflozin in nepalese type 2 diabetes patients
Date not available
The safety of dopamine agonists: clinical perspectives
2010-01-0404Jan2010
&#146;Think Adrenal&#146;: An innovative trust-wide safety and education programme designed for the care of patients with adrenal insufficiency
2021-08-1111Aug2021
Regulation and dysregulation of appetite and satiety
2017-03-0505Mar2017
Brain Satiety Responses to a Meal in Children Before and After Weight Management Intervention
Date not available
Safety of lanreotide in infants with congenital hyperinsulinism
Date not available
11.15. Impaired brain satiety responses after weight loss in children with obesity
2022-12-0909Dec2022
A randomised phase 3 trial to assess efficacy and safety of CAM2029, an octreotide subcutaneous depot, in patients with acromegaly
2024-06-0505Jun2024
An Open-Label Extension Study to Evaluate the Safety of Long-term Use of Relacorilant in Patients With Endogenous Cushing Syndrome
2023-02-0505Feb2023
Improving safety in diabetes management and reducing insulin errors in hospital &#150; practically achievable or a utopian fantasy?
2017-03-0505Mar2017
Latest safety outcomes from the PATRO adults study of omnitrope<sup>&#174;</sup> for the treatment of adult patients with growth hormone deficiency
2018-08-0505Aug2018
Efficacy and safety of an outpatient low radioide dose for remnant thyroid ablation in low risk papillary thyroid carcinoma (PTC)
2015-01-0505Jan2015
Long-term efficacy and safety of once-monthly pasireotide in patients with Cushing&#146;s disease: A Phase III extension study
2018-08-0505Aug2018
Analysis of UK patients in PATRO children: a non-interventional study of the long-term safety and efficacy of Omnitrope in children
Date not available
Effect of Ramadan fasting on glycaemic control in type 2 diabetic patients on oral hypoglacaemic agents
Date not available
Dasiglucagon safety in paediatric participants with CHI
Date not available
Does standardising the dynamic endocrine testing process improve patient communication and safety?
2017-03-0505Mar2017
Efficacy and safety of long-term treatment with monthly calcifediol soft capsules in vitamin D deficient patients
Date not available
Real world efficacy and safety of multikinase inhibitors in patients with advance differentiated thyroid cancer
2023-02-0505Feb2023
Effectiveness and Safety of Re-Treatment With 177Lu-DOTATATE in Patients With Progressive NETs in the US: a Retrospective Real-World Study
2023-01-0202Jan2023
Safety of growth hormone replacement in patients with non-irradiated pituitary and peri-pituitary tumours
2007-01-0303Jan2007
Efficacy, outcome and safety of SGLT2-I in patients with type II diabetes meta analysis review
Date not available
The PATRO adults study of Omnitrope<sup>&#174;</sup> for the treatment of adult patients with growth hormone deficiency: latest safety results
2019-01-0505Jan2019
Efficacy and safety of radiofrequency thermal ablation in the treatment of thyroid nodules with pressure symptoms in elderly patients
Date not available
Ongoing, open-label, multicenter, expanded-access study demonstrating the safety and efficacy of pasireotide sc in patients with Cushing's disease
2015-01-0505Jan2015
Safety and efficacy of efpegerglucagon in patients with congenital hyperinsulinism: interim results from a phase 2 study
Date not available
Bilateral femoral fractures in a pacient with primary hyperparathyroidism: A case report
2019-01-0505Jan2019
Lobectomy outcomes in patients with low-risk differentiated thyroid cancer: oncologic and safety outcomes at a swiss tertiary referral center
Date not available
Long-term safety of diazoxide choline extended-release (DCCR) tablets in patients with prader-willi syndrome
2022-07-0505Jul2022
Two cases of peri-operative adrenal crises: lessons in patient safety
Date not available
Normal adult height in a pacient with untreated congenital hypopituitarism: a case report
2023-02-0505Feb2023
2.8. Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study
2019-12-0909Dec2019
Cardiovascular safety; which antidiabetic agent will be your choice in patients, who have coexisting cardiovascular disease?
Date not available
A case of aggressive corticotropinoma in a patient after combined treatment and bilateral adrenalectomy
2024-06-0505Jun2024
Safety and Efficacy of Treatment with Long-Acting Lanreotide Autogel&#174; in Early Infancy in Patients with Congenital Hyperinsulinism
Date not available
Efficacy and safety of lanreotide in combination with pegvisomant in clinical practice in patients with active acromegaly with monotherapy failure
2013-01-0404Jan2013
Safety and Efficacy of Radiofrequency Ablation of Thyroid Nodules. Our Experience With A Cohort of 43 Patients
2023-02-0505Feb2023
Methodology of the SORENTO Clinical Trial: Assessing Efficacy and Safety of High Exposure Octreotide Subcutaneous Depot in Patients with GEP-NET
2023-01-0202Jan2023
A randomized, double-blind, placebo-controlled, multicenter phase III trial of everolimus in patients with advanced pancreatic neuroendocrine tumors (PNET) (RADIANT-3): updated safety results
2011-01-0404Jan2011
Long-term safety and efficacy of subcutaneous pasireotide in patients with cushing&#146;s disease: results from a non-interventional study
2024-06-0505Jun2024
Efficacy and safety of volanesorsen for the treatment of metabolic complications in patients with familial partial lipodystrophy: results of the BROADEN study
Date not available
Methodology of the SORENTO clinical trial: assessing the efficacy and safety of high exposure octreotide subcutaneous depot in patients with GEP-NETs
2022-07-0505Jul2022
Safety and Effectiveness of Growth Hormone Treatment in Patients with Prader-Willi Syndrome under 2 Years of Age in a Reference Hospital
Date not available
Effectiveness and safety of combined therapy with low dose ketoconazole and cabergoline in patients with Cushing&#146;s disease partially responsive to monotherapy with cabergoline
2009-01-0404Jan2009
Trial design of a phase III, multicentre, randomised, double-blind, placebo-controlled, 48-week study to evaluate the safety and efficacy of osilodrostat in patients with Cushing&#146;s disease
Date not available
Impact of physical activity and its maintenance in the efficacy and safety of tyrosine kinase inhibitors in advanced thyroid carcinoma patients
Date not available
The effect of lifestyle intervention on glycaemic variation, quality of life and satiety levels in children and young people with obesity
Date not available
Evaluation of perior-operational safety and efficiency of the laparoscopic gastroplication procedure compared to laparoscopic handle gasstroektomia in patients with overweight and metabolic syndrome
2019-01-0505Jan2019
Effectiveness and safety of candesartan cilexetil/hydrochlorothiazide combination in jordanian hypertensive patients at risk of cardiovascular disease
2019-01-0505Jan2019
Status of the ongoing SORENTO clinical trial: Assessing efficacy and safety of high-exposure octreotide subcutaneous depot in patients with GEP-NET
Date not available
Efficacy and safety of combined treatment with somatostatin analogues (SA) AND pegvisomant (PEG) in acromegalic patients resistant to SA
2010-01-0404Jan2010
Favorable liver safety profile of the selective glucocorticoid receptor modulator relacorilant in healthy and hepatically impaired adults and in patients with cushing syndrome
2022-07-0505Jul2022
Safety of growth hormone and cardiovascular outcomes in patients with Noonan syndrome enrolled in NordiNet&#174; International Outcome Study (IOS) and the ANSWER Program
2021-06-0909Jun2021
Efficacy and safety of telotristat ethyl in patients with carcinoid syndrome inadequately controlled by somatostatin analogs: Analysis of the completed TELESTAR extension period
Date not available
Long-term Safety and Effectiveness of Growth Hormone in Pediatric Patients with Growth Disorders in Korea: A 10-Year Interim Analysis of the LG Growth Study
Date not available
Evaluation of safety and tolerability of calcitonin stimulation using high-dose calcium in patients with medullary thyroid carcinoma (MTC)
2011-01-0404Jan2011
NETTER-1 Phase III in Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-Dotatate: Efficacy, Safety, QoL Results and Subgroup Analysis
Date not available
Efficacy and safety of monthly oral minodronate for the treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients
2013-01-0404Jan2013
The N221D Variant in PCSK1 is Highly Prevalent in Childhood Obesity and Can Influence Patients&acute; Metabolic Profile
Date not available
2.2. Safety and efficacy of pediatric growth hormone therapy: results from the full KIGS cohort
2023-08-0909Aug2023
Efficacy and Safety of Insulin Glargine in Type-2 Diabetes Mellitus Patients with Moderate Renal Failure
2012-01-0505Jan2012
Safety and efficacy of different insulin regimens in treatment of type 2 diabetic patients who insist to fast during Ramadan 1437 (Hijri) In Fayoum Governorate, Egypt
2018-08-0505Aug2018
Safety and efficacy of long-acting Pasireotide monotherapy in acromegalic patients treated with a combination of first-generation somatostatin analogs and cabergoline or pegvisomant
2018-08-0505Aug2018
GLP1 agonists improve glycaemic dysregulation, satiety levels and quality of life in adolescents with obesity
Date not available
Impaired Brain Satiety Responses by Functional Neuroimaging After Weight Loss Therapy in Children with Obesity
Date not available
Efficacy and safety of lanreotide in combination with cabergoline in clinical practice in patients with active acromegaly with monotherapy failure
2013-01-0404Jan2013
Comparison of the effects on comorbidities and the safety of gastric bypass and sleeve gastrectomy in morbid obesity patients
Date not available
Efficacy and safety of telotristat etiprate in patients with carcinoid syndrome not adequately controlled by somatostatin analog therapy: Analysis of the ongoing TELESTAR extension period
Date not available
Adult Height of Patients Enrolled in PATRO Children, An Ongoing Observational Study of the Long-term Safety And Effectiveness Of Omnitrope<sup>&#174;</sup>
Date not available
Long-term safety and effectiveness of recombinant human growth Hormone inKorean pediatric patients with growth disorders: 9-year interim analysis fromLG Growth Study
Date not available
Efficacy and safety of long-acting pasireotide in acromegalic patients in the real life: The reappraisal of the first-dose follow-up visit
Date not available
The efficacy and safety of 12 weeks Anethum graveolens on waist circumference and triglyceride in patients with metabolic syndrome
Date not available
Design, build and implementation of a solution for prescribing, monitoring and administration of insulin within an inpatient electronic patient record &#150; the st james&#146;s hospital experience
Date not available
Efficacy and safety of long-acting pasireotide (LA-PAS) in patients with uncontrolled acromegaly: Results from the prospective cohort of european observational acronis study
Date not available
Evaluation of the Safety and Usability of FlexPro<sup>&#174;</sup> 30 mg/3 ml, for the Delivery of Norditropin<sup>&#174;</sup> in Patients Requiring GH Therapy
Date not available
<sup>177</sup>Lu-DKFZ-PSMA-617 therapy in metastatic castration resistant prostate cancer: safety, efficacy and quality of life assessment
Date not available
Clinical implications of the gut microbiome in anaplastic thyroid cancer
Date not available
Real-world effectiveness and safety of semaglutide for weight loss
Date not available
Safety profile of growth hormone replacement (GHr) in GH deficient patients during transition period treated for intracranial tumors and malignancy in childhood- Single center expirence
2024-06-0505Jun2024
Effects on Near-adult Height and Safety of Recombinant Human Growth Hormone in Growth Hormone Deficiency and Turner Syndrome Patients: Results from the LG Growth Study
Date not available
Long-term effectiveness and safety data from the Global Increlex<sup>&reg;</sup> Registry in patients treated with rhIGF-1: Subgroup analysis of na&iuml;ve pre-pubertal patients and patients with Laron syndrome
Date not available
An open-label, randomized, controlled study of the effectiveness and safety of a high intensity focused ultrasound device compared with observation in patients with non-malignant cold thyroid nodules
2013-01-0404Jan2013
Testosterone implant therapy: efficacy and safety in transmen and native men with hypogondism
2014-01-0303Jan2014
8.9. Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase
Date not available
Combined treatment for acromegaly with long-acting somatostatin analogues and pegvisomant: long-term safety up to 4.5 years of follow-up in 86 patients
2009-01-0404Jan2009
A delayed diagnosis of Graves&#146; disease in a patent with severe hyperthyroidism-associated hypercalcaemia
Date not available
Trial design of phase IIIb, open-label, single arm study to evaluate efficacy and safety of pasireotide LAR in patients with inadequately-controlled acromegaly despite treatment with first-generation somatostatin analogues
2015-01-0505Jan2015
Temporary oral NaCl tablets safely increase serum sodium in hospitalised elderly patients with hyponatraemia secondary to refractory idiopathic syndrome of inappropriate diuresis (SIAD)
Date not available
The effect of snack foods containing rare sugars on glycaemic response, gut hormones and satiety in healthy UK adults
Date not available
Evaluation of the efficacy and safety of pasireotide LAR in patients with mild-to-moderate cushing&#146;s disease: a randomized, double-blind, multicenter, phase III study design
2012-01-0505Jan2012
Long-Term Safety and Effectiveness of Recombinant Human Growth Hormone in Korean Pediatric Patients with Growth Disorders: 7-year Interim Analysis from LG Growth Study
Date not available
Kisspeptin-54 safely and effectively triggers oocyte maturation during IVF treatment in women at high risk of developing ovarian hyperstimulation syndrome (OHSS)
2015-12-1010Dec2015
Safety and efficacy of atorvastatin treatment in children with familial hypercholesterolaemia
2015-04-1111Apr2015
Clinical characteristics and outcomes of patients with myxedema coma: a 15-years experience of a tertiary care center in Thailand
2017-03-0505Mar2017
Predicting liver fibrosis using artificial intelligence in obese patiens
2024-06-0505Jun2024
A randomized, double-blind, placebo-controlled, multicenter phase III trial of everolimus + octreotide LAR versus placebo + octreotide LAR in patients with advanced neuroendocrine tumors (NET) (RADIANT-2): updated safety results
2011-01-0404Jan2011
Radiotherapy for pituitary adenomas &#150; safety and efficacy analysis
2018-08-0505Aug2018
Efficacy and safety of the use of the recombinant GH receptor antagonist pegvisomant (PGV) in acromegaly. Evaluation of its use in 13 patients treated in a pituitary disorders unit
2011-01-0404Jan2011
Biochemical response and imaging changes in 99mtc-mibi in patiens with primary hyperparathyroidism treated with Cinacalcet
Date not available
Efficacy and Safety of Denosumab Treatment in a Boy with Cherubism
Date not available
Growth hormone replacement in patients with treated germ cell tumours: safety issues
2008-01-0404Jan2008
Cardiovascular and metabolic safety of growth hormone treatment in adult patients with growth hormone deficiency: real-world data from two large studies in the USA and Europe
Date not available
Development of a Parent Experience Measure for Parents of Children with Achondroplasia
Date not available
Effects of Eating Rate on Satiety Hormones, Meal Enjoyment and Memory for Recent Eating: An fMRI Study
Date not available
Efficacy, safety and adherence to treatment of teriparatide: an observational study
2012-01-0505Jan2012
Safety of pharmacological treatment of thyroid diseases during pregnancy
2006-04-1212Apr2006
Efficacy and safety of bilateral epiphysiodesis in extremely tall adolescents
Date not available
A Phase 3b, open-label, extension study to evaluate the long-term safety of once-daily, dual-release hydrocortisone (DR-HC) in patients with adrenal insufficiency (AI)
Date not available
Assessing long-term safety and efficacy of osilodrostat in prior- and new-use patients with endogenous cushing&#146;s syndrome: a 1-year real-world interim analysis of the non-interventional, multinational LINC 6 study
2024-06-0505Jun2024
Pro12Ala PPAR gamma2 gene polymorphism in PCOS women - the role of the satiety and insulin activity regulating compounds
2006-04-1212Apr2006
Long-term safety of long-acting somatostatin analogues in combination with pegvisomant in 133 acromegalic patients, a retrospective single centre study with follow up for up to 8 years
2013-01-0404Jan2013
11&#946;-HSD type 1 inhibitor ameliorates metabolic disorders associated with hypercortisolemia: A clinical trial to assess its safety and efficacy in Japanese patients with refractory Cushing&#146;s syndrome and subclinical Cushing&#146;s syndrome
2018-02-1111Feb2018
An open, multi-centre, phase IIIB, long term follow-up study to assess the safety, tolerability and efficacy of once-daily oral dual-release hydrocortisone in patients with adrenal insufficiency
2012-01-0505Jan2012
HOW TO OPTIMISE PEGVISOMANT TREATMENT OF ACROMEGALY SAFELY?
2002-01-1111Jan2002
A comparison between the efficacy and safety of pegvisomant to that of octreotide LAR in patients with acromegaly
Date not available
Characteristics, Effectiveness and Safety Data from Clinically Relevant Subgroups of Patients with Severeprimary IGF-I Deficiency (SPIGFD): Results from the European Increlex<sup>&#174;</sup> Growth Forum Database (EU-IGFD) Registry
Date not available
Phase 1/2 open-label trial to assess the safety and preliminary efficacy of <sup>177</sup>Lu-OPS201 as peptide receptor radionuclide therapy in patients with somatostatin receptor-positive, progressive neuroendocrine tumours
Date not available
Efficacy and safety of lanreotide Autogel treatment for carcinoid syndrome in patients with gastroenteropancreatic neuroendocrine tumors: results of ELECT, a large multinational phase 3 study
Date not available
Efficacy and safety of co-administration of lanreotide Autogel 120 mg monthly with pegvisomant weekly in patients with acromegaly partially controlled by somatostatin analogues
2010-01-0404Jan2010
Rare heterozygous variants in genes of the leptin-melanocortin satiety pathway contribute to childhood obesity
2021-06-0909Jun2021
Efficacy and Safety across Subgroups in Children with Congenital Hyperinsulinism Treated with Dasiglucagon
Date not available
Outcome squares integrating efficacy and safety, as applied to functioning pituitary adenoma surgery
Date not available
A phase 1 clinical trial evaluating the safety and efficacy of up to two administrations of the adrenal PET tracer [<sup>18</sup>F]CETO in healthy volunteers and patients with primary aldosteronism
Date not available
Prospective, multi-country, observational study of patients with endogenous Cushing&#146;s syndrome exposed to Ketoconazole (using the existing European Registry on Cushing&#146;s Syndrome (ERCUSYN)), to assess drug use, safety and effectiveness
2024-06-0505Jun2024
Evaluation series on safety and efficacy of nutritional supplements (ESSENS) in newly diagnosed hyperglycaemia
2015-01-0505Jan2015
Lactation litter size differentially affects satiety hormone concentrations and gut adaptations in Wistar rat dams
Date not available
Long-term results from the Phase III LINC 4 study: Osilodrostat maintained normal mean urinary free cortisol in patients with Cushing&#146;s disease, with a favourable safety profile
2022-07-0505Jul2022
A double-blind, randomized, placebo-controlled phase 3 study to assess the efficacy and safety of relacorilant, a selective glucocorticoid receptor modulator, in patients with hypercortisolism due to cortisol-secreting adrenal adenoma(s)/hyperplasia
Date not available
Efficacy and safety of transarterial chemoembolization of unresectable neuroendocrine liver metastases
Date not available
Normal Minipuberty in a Patient with DAX1 Mutation: a Reliable Marker of the Function of the Hypothalamic&#150;Pituitary&#150;Gonadal Axis?
Date not available
BUR-CL207: An Open-label, Multicenter, Non-randomized Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Burosumab in Pediatric Patients from Birth to Less than 1 Year of Age with XLH.
2021-06-0909Jun2021
Liraglutide as additional treatment to insulin in patient with latent autoimmune diabetes in adults (LADA): a case report
Date not available
Efficacy and safety of bisphosphonate treatment in pediatric patients with osteoporosis caused by immobilization
Date not available
EFFICACY AND SAFETY OF TITRATED-DOSES LANREOTIDE AUTOGEL IN PATIENTS WITH ACROMEGALY
2003-01-1111Jan2003
Dapagliflozin clinical experience and safety on patients with type 2 diabetes and obesity
Date not available
Effects on comorbidities and safety of bariatric surgery in morbid obesity patients
2018-08-0505Aug2018
Efficacy and safety of radiofrequency ablation performed by an endocrinologist for large benign thyroid nodules
2015-01-0505Jan2015
Efficacy and safety of high dose testosterone therapy in partial androgen insensitivity
2002-01-0303Jan2002
Characteristics, effectiveness and safety data for patients with growth failure treated with recombinant IGF-1 and achieving adult or near-adult height: results from the Increlex<sup>&reg;</sup> Global Registry
Date not available
Safety and efficiency of short-term glucocorticoid treatment in laryngological patients &#150; pilot study
2024-06-0505Jun2024
Efficacy and safety of lanreotide autogel (LAN-ATG) 120 mg at extended dosing intervals (EDIs) in acromegalic patients biochemically controlled with octreotide LAR (OCT-LAR) 10 or 20 mg: The LEAD study
Date not available
Safety review of liothyronine use: a 20 year observational follow up study
2015-12-1010Dec2015
The evaluation of the effectiveness and safety of transarterial embolisation of to the liver metastasised neuroendocrine tumours
2015-01-0505Jan2015
Efficacy and safety of intravenous infusion of ibandronic acid in children with osteogenesis imperfecta
Date not available
Vitamin D inadequacy in patientes who are screened for osteoporosis
2009-01-0404Jan2009
Efficacy and safety of switching to pasireotide LAR monotherapy or in combination with pegvisomant in acromegaly patients controlled with combination therapy of somatostatin analogues and pegvisomant (PAPE study): a prospective, open-label 48 week study
2018-08-0505Aug2018
Safety results from MPOWERED, a phase 3 trial of oral octreotide capsules in adults with acromegaly
Date not available
Efficacy, Safety and Tolerability of Liraglutide, GLP-1 Analogue, in Indian Adolescent Population with Obesity
Date not available
The safety and efficacy of iopanoic acid in the pre-surgical management of thyrotoxicosis
Date not available
Diabetes insipidus safety: Automated electronic records alert to identify patients with diabetes insipidus in hospital
Date not available
Efficacy and safety of lenvatinib in a cohort of well-differentiated advanced thyroid carcinomas
2022-02-0909Feb2022
Effects and safety of growth hormone (GH) treatment in 6 children with pycnodysostosis
Date not available